# Pravastatin Efficacy and Safety Trial in Hypercholesterolemic Patients With Chronic Liver Disease

> **NCT00529178** · PHASE4 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 232 (estimated)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Pravastatin

## Key facts

- **NCT ID:** NCT00529178
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** 2005-03
- **Final completion:** 2005-03
- **Target enrollment:** 232 (ESTIMATED)
- **Last updated:** 2011-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00529178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00529178, "Pravastatin Efficacy and Safety Trial in Hypercholesterolemic Patients With Chronic Liver Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00529178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*